Point72 Asset Management L.P. Takes 2.38 Million Position in Accolade, Inc. - MarketBeat
ACCD Stock | USD 3.66 0.02 0.55% |
About 56% of Accolade's investor base is looking to short. The analysis of the overall investor sentiment regarding Accolade suggests that many traders are alarmed. The current market sentiment, together with Accolade's historical and current headlines, can help investors time the market. In addition, many technical investors use Accolade stock news signals to limit their universe of possible portfolio assets.
Accolade |
Point72 Asset Management L.P. Takes 2.38 Million Position in Accolade, Inc. MarketBeat
Read at news.google.com
Accolade Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Accolade can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Accolade Fundamental Analysis
We analyze Accolade's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accolade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accolade based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Accolade is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Accolade Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accolade stock to make a market-neutral strategy. Peer analysis of Accolade could also be used in its relative valuation, which is a method of valuing Accolade by comparing valuation metrics with similar companies.
Peers
Accolade Related Equities
EVH | Evolent Health | 4.72 | ||||
PHR | Phreesia | 2.40 | ||||
DH | Definitive Healthcare | 1.49 | ||||
HCAT | Health Catalyst | 0.12 | ||||
PINC | Premier | 0.09 | ||||
HSTM | HealthStream | 0.55 | ||||
NRC | National Research | 0.83 | ||||
PRVA | Privia Health | 1.16 | ||||
CERT | Certara | 2.59 | ||||
CMAX | CareMax | 15.63 |
Complementary Tools for Accolade Stock analysis
When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |